Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Verus Pharmaceuticals

2002 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
$310M LATEST DEAL AMOUNT
Description

Provider of solutions for the treatment of asthma, allergies, and related diseases and conditions. The company also offers Twinject, an epinephrine auto-injector for anaphylaxis. It is differentiated by its pediatric orientation and its strong financial position and experienced management team, which allows the company to capitalize on an extensive network to build its product portfolio and pursue complementary transactions.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Acquirer
Primary Office
  • 12671 High Bluff Drive
  • Suite 200
  • San Diego, CA 92130
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Verus Pharmaceuticals’s full profile, request a free trial.

Verus Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 24-Sep-2007 $310M 0000 00000 Completed Product Development
1. Early Stage VC (Series A) 10-Jun-2005 0000 0000 00000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Verus Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00.0 00.0 00.0 00.000
To view this company’s complete Cap Table, request access »

Verus Pharmaceuticals Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000-00000 00 06-Jul-2005 000000000 00000 00 Therapeutic Devices 000000 00000
To view this company’s complete investment and acquisition history, request access »

Verus Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000-00000 00 06-Jul-2005 000000000 00000 00 Completed
  • 00000 000000000000
To view this company’s complete exits history, request access »

Verus Pharmaceuticals Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Athenian Venture Partners Venture Capital Minority 000 0000 000000 0
CDIB BioScience Venture Management Venture Capital Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
Greenspring Associates Venture Capital Minority 000 0000 000000 0
MPM Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Verus Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Robert Keith President & Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »